Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 4, 2010 (rev. 1)

Premium

Genstruct has appointed David de Graaf as its chief scientific officer.

De Graaf most recently served as vice president of biotherapeutics and integrative biology at Boehringer-Ingelheim. Prior to that, he was director of systems biology at Pfizer and built the first systems biology team at AstraZeneca.

Before his career in industry, de Graaf was a researcher at the Weizmann Institute of Science and the Center for Genome Research at Whitehead/MIT.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more